Dr. Stephen Hand, MD

NPI: 1144225566
Total Payments
$7,712
2024 Payments
$1,200
Companies
47
Transactions
467
Medicare Patients
5,550
Medicare Billing
$489,707

Payment Breakdown by Category

Food & Beverage$7,662 (99.3%)
Education$50.18 (0.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,662 461 99.3%
Education $50.18 6 0.7%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $1,184 101 $0 (2024)
Actelion Pharmaceuticals US, Inc. $844.02 41 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $738.60 46 $0 (2024)
AstraZeneca Pharmaceuticals LP $623.92 35 $0 (2024)
United Therapeutics Corporation $480.68 18 $0 (2024)
Electromed, Inc. $358.69 28 $0 (2024)
Philips Electronics North America Corporation $338.02 17 $0 (2022)
Genentech USA, Inc. $285.68 20 $0 (2023)
Merck Sharp & Dohme LLC $283.65 18 $0 (2024)
Grifols USA, LLC $258.78 15 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,200 63 AstraZeneca Pharmaceuticals LP ($178.20)
2023 $1,004 53 GlaxoSmithKline, LLC. ($130.59)
2022 $490.99 26 Boehringer Ingelheim Pharmaceuticals, Inc. ($64.83)
2021 $483.23 30 Actelion Pharmaceuticals US, Inc. ($73.56)
2020 $714.46 45 GlaxoSmithKline, LLC. ($127.62)
2019 $1,514 98 GlaxoSmithKline, LLC. ($240.83)
2018 $1,234 86 GlaxoSmithKline, LLC. ($251.66)
2017 $1,071 66 GlaxoSmithKline, LLC. ($160.27)

All Payment Transactions

467 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/18/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $18.38 General
Category: Respiratory
12/17/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $11.43 General
Category: HFCWO
12/04/2024 Takeda Pharmaceuticals U.S.A., Inc. GLASSIA (Biological) Food and Beverage In-kind items and services $17.67 General
Category: IMMUNOLOGY
11/20/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $12.17 General
Category: RESPIRATORY
11/19/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $24.58 General
Category: Respiratory
11/14/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $1.80 General
Category: HFCWO
11/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $34.53 General
Category: Immunology
11/12/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $23.50 General
Category: Immunology and Neurology
11/06/2024 Axsome Therapeutics, Inc. Sunosi (Drug) Food and Beverage In-kind items and services $22.31 General
Category: Neurology
10/30/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $5.47 General
Category: RESPIRATORY
10/28/2024 CSL Behring Hizentra (Biological) Food and Beverage In-kind items and services $13.63 General
Category: Immunology
10/23/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $35.53 General
Category: INFLAMMATION AND IMMUNOLOGY
10/17/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $23.39 General
Category: Respiratory
10/15/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $20.77 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/09/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $17.50 General
Category: HFCWO
10/03/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $13.17 General
Category: IMMUNOLOGY
10/02/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.65 General
Category: RESPIRATORY
09/18/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $30.88 General
Category: NEUROLOGY
09/17/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $24.67 General
Category: Respiratory
09/04/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $29.03 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
08/29/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $18.65 General
Category: RESPIRATORY
08/27/2024 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $15.75 General
Category: Pulmonology
08/22/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $6.11 General
Category: RESPIRATORY
08/21/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $25.00 General
08/15/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $11.88 General
Category: HFCWO

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 1,219 1,547 $317,981 $95,659
2022 20 1,155 1,456 $293,061 $86,517
2021 19 1,404 1,990 $454,749 $140,147
2020 27 1,772 2,520 $547,983 $167,384
Total Patients
5,550
Total Services
7,513
Medicare Billing
$489,707
Procedure Codes
86

All Medicare Procedures & Services

86 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 176 269 $71,285 $25,028 35.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 110 275 $51,975 $16,406 31.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 204 229 $42,594 $14,334 33.7%
99291 Critical care, first 30-74 minutes Facility 2023 30 59 $34,161 $9,659 28.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 49 51 $18,207 $4,854 26.7%
95810 Sleep study in sleep lab (6 years or older) Facility 2023 48 50 $19,276 $4,254 22.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 55 55 $12,485 $4,175 33.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 26 26 $8,892 $3,137 35.3%
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) Facility 2023 30 34 $13,142 $2,927 22.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 21 22 $11,594 $2,853 24.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 26 31 $8,401 $2,671 31.8%
94618 Test for exercise-induced lung stress Facility 2023 70 72 $4,392 $1,183 26.9%
95806 Sleep study including heart rate, breathing, airflow, and effort Facility 2023 37 37 $4,403 $1,086 24.7%
31624 Irrigation and suction of lung airways to obtain cells using an endoscope Facility 2023 14 14 $6,505 $707.02 10.9%
94729 Test to examine how well the lungs exchange gases Facility 2023 99 99 $2,960 $643.71 21.7%
94726 Test to determine lung volumes using sensors Facility 2023 64 64 $2,112 $558.84 26.5%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 61 61 $2,371 $442.72 18.7%
94010 Test to measure expiratory airflow and volume Facility 2023 54 54 $1,510 $327.95 21.7%
94727 Test to determine lung volumes using gas dilution or washout Facility 2023 34 34 $1,122 $300.12 26.7%
95012 Test to measure the level of nitric oxide gas Office 2023 11 11 $594.00 $110.16 18.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 157 226 $59,890 $19,966 33.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 223 244 $45,384 $14,076 31.0%
99291 Critical care, first 30-74 minutes Facility 2022 32 84 $48,636 $13,346 27.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 96 227 $42,903 $12,133 28.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 64 64 $14,528 $4,222 29.1%

About Dr. Stephen Hand, MD

Dr. Stephen Hand, MD is a Critical Care Medicine healthcare provider based in Anderson, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144225566.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Hand, MD has received a total of $7,712 in payments from pharmaceutical and medical device companies, with $1,200 received in 2024. These payments were reported across 467 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($7,662).

As a Medicare-enrolled provider, Hand has provided services to 5,550 Medicare beneficiaries, totaling 7,513 services with total Medicare billing of $489,707. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Pulmonary Disease, Sleep Medicine
  • Location Anderson, SC
  • Active Since 06/14/2005
  • Last Updated 04/09/2012
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1144225566

Products in Payments

  • TRELEGY ELLIPTA (Drug) $539.57
  • UPTRAVI (Drug) $467.70
  • OFEV (Drug) $413.01
  • SMARTVEST (Device) $358.69
  • ORENITRAM (Drug) $326.10
  • OPSUMIT MACITENTAN (Drug) $316.39
  • DUPIXENT (Biological) $289.55
  • NUCALA (Biological) $281.78
  • SYMBICORT (Drug) $277.48
  • STIOLTO RESPIMAT (Drug) $251.58
  • Arikayce (Drug) $243.79
  • GLASSIA (Biological) $226.14
  • Xolair (Biological) $194.26
  • ANORO (Drug) $181.84
  • Prolastin-C Liquid (Biological) $177.46
  • Sunosi (Drug) $154.70
  • ZERBAXA (Drug) $151.58
  • FASENRA (Biological) $121.03
  • TYVASO (Drug) $115.33
  • RUCONEST (Biological) $92.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Anderson